| Literature DB >> 25648599 |
Mohammed A Al-Omair1, Abdelwahed R Sayed2,3, Magdy M Youssef4,5.
Abstract
An expedient synthesis of novel triazoles,Entities:
Mesh:
Substances:
Year: 2015 PMID: 25648599 PMCID: PMC6272378 DOI: 10.3390/molecules20022591
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Synthesis of 2-hydroxy-N-phenylbenzohydrazonoyl bromide 4.
Scheme 2Synthesis of triazoline derivatives 9 and 10.
Scheme 3Synthesis of triazolines 12–14 and tetrazine 15.
Scheme 4Synthesis of thiadiazoles 20 and 21.
Scheme 5Synthesis of thiadiazole 24.
Scheme 6Synthesis of dihydrazones 26.
Effect of compounds on Gram-negative and Gram-positive microorganisms. Results expressed as inhibition zone diameter in mm.
| Compound No. | Gram-Negative | Gram-Positive | ||
|---|---|---|---|---|
| 15 | 13 | 16 | 18 | |
| 17 | 14 | 19 | 20 | |
| 13 | 12 | 14 | 15 | |
| 12 | 11 | 13 | 14 | |
| 14 | 13 | 15 | 16 | |
| 12 | 11 | 14 | 14 | |
| 13 | 11 | 14 | 16 | |
| 12 | 12 | 13 | 15 | |
| 18 | 16 | 18 | 21 | |
| 13 | 12 | 13 | 15 | |
| 12 | 14 | 12 | 16 | |
| 13 | 14 | 12 | 17 | |
| 12 | 11 | 13 | 14 | |
| 13 | 12 | 14 | 13 | |
| 14 | 13 | 15 | 17 | |
| 9 | 11 | 11 | 10 | |
| 21 | 20 | 20 | 21 | |
| 20 | 18 | 22 | 24 | |
Minimum inhibitory concentration (μg/mL) of compounds against Gram-negative and Gram-positive microorganisms.
| Compound No. | Gram-Negative | Gram-Positive | ||
|---|---|---|---|---|
| 25 | 30 | 30 | 35 | |
| 15 | 15 | 20 | 20 | |
| 35 | 40 | 35 | 45 | |
| 40 | 45 | 50 | 50 | |
| 20 | 30 | 35 | 35 | |
| 45 | 40 | 45 | 50 | |
| 40 | 45 | 50 | 40 | |
| 35 | 40 | 50 | 45 | |
| 15 | 20 | 20 | 20 | |
| 30 | 35 | 35 | 35 | |
| 30 | 30 | 35 | 35 | |
| 25 | 35 | 40 | 35 | |
| 40 | 45 | 45 | 55 | |
| 45 | 45 | 55 | 50 | |
| 35 | 40 | 40 | 35 | |
| 55 | 50 | 70 | 50 | |
| 15 | 20 | 20 | 20 | |
| 10 | 15 | 15 | 15 | |
Figure 1A figure showing the degradation effect of 4 μg of series (Lanes 3–19) on the genomic DNA isolated from E. coli, Lane1 E. coli DNA and lane 2 E. coli DNA + DMSO.
Superoxide dismutase mimetic catalytic activity of compounds as antioxidant enzyme.
| Compound No. | Δ through 4 min | % Inhibition |
|---|---|---|
| 0.548 | — | |
| 0.169 | 69.2 | |
| 0.297 | 45.8 | |
| 0.264 | 51.8 | |
| 0.326 | 40.5 | |
| 0.364 | 33.6 | |
| 0.272 | 50.4 | |
| 0.381 | 30.5 | |
| 0.332 | 39.4 | |
| 0.337 | 38.5 | |
| 0.273 | 50.2 | |
| 0.305 | 44.3 | |
| 0.314 | 42.7 | |
| 0.308 | 43.8 | |
| 0.382 | 30.3 | |
| 0.358 | 34.7 | |
| 0.294 | 46.4 | |
| 0.386 | 29.6 | |
| 0.256 | 53.3 |
Figure 2Antioxidant activities of compounds using DPPH.
Figure 3Antioxidant activities of compounds using ABTS.
Figure 4Antioxidant activities of compounds using NO.